series-b
Stage
1
Investors
About
Talaris Therapeutics develops cell therapy products aimed at inducing immune tolerance to prevent organ transplant rejection and treat immune-mediated diseases.
Explore Talaris Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.